In vitro and in vivo characterization of a recombinant rhesus cytomegalovirus containing a complete genome. (2020)
Attributed to:
Utilising proteomics to develop anti-HCMV immunotherapy
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1371/journal.ppat.1008666
PubMed Identifier: 33232376
Publication URI: http://europepmc.org/abstract/MED/33232376
Type: Journal Article/Review
Volume: 16
Parent Publication: PLoS pathogens
Issue: 11
ISSN: 1553-7366